Effects of galantamine on cognitive deficits in smokers and non-smokers with schizophrenia

Schizophr Res. 2008 Aug;103(1-3):326-7. doi: 10.1016/j.schres.2008.05.004. Epub 2008 Jun 20.
No abstract available

Publication types

  • Letter
  • Randomized Controlled Trial
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use*
  • Attention
  • Cognition Disorders / diagnosis*
  • Cognition Disorders / psychology
  • Double-Blind Method
  • Female
  • Galantamine / therapeutic use*
  • Humans
  • Male
  • Memory, Short-Term
  • Middle Aged
  • Neuropsychological Tests
  • Psychomotor Performance
  • Schizophrenia / diagnosis
  • Schizophrenia / drug therapy*
  • Schizophrenic Psychology*
  • Smoking / psychology*
  • Smoking Cessation / psychology

Substances

  • Angiotensin-Converting Enzyme Inhibitors
  • Galantamine